本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

25.12
-0.6100-2.37%
盤後24.60-0.5350-2.13%19:28 EDT
成交量:133.13萬
成交額:3,350.73萬
市值:31.72億
市盈率:-13.77
高:25.99
開:25.99
低:24.74
收:25.73
52周最高:35.72
52周最低:16.10
股本:1.26億
流通股本:7,811.99萬
量比:0.45
換手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
淨資產收益率:-108.49%
總資產收益率:-13.77%
市淨率:20.30
市盈率(LYR):-15.73

資料載入中...

2025/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

重要事件披露

Form 8-K - Current report
2025/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/21

重要事件披露

Form 8-K - Current report